These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 6779465)

  • 1. [Features of potassium metabolism in progressive muscular dystrophy].
    Sitnikov VF; Leskova NN; Potashnikova NP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(11):1617-20. PubMed ID: 6779465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An autoradiographic study of muscular dystrophy, motor neuron disease and Charcot-Marie-Tooth disease.
    Monckton G; Marusyk H
    Can J Neurol Sci; 1977 Feb; 4(1):25-9. PubMed ID: 837261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Plasma and erythrocyte free amino acids in patients with progressive muscular dystrophy].
    Temin PA; Toguzov RT; Griniu LP; Kushelev AR; Dzhutova ED
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(11):29-33. PubMed ID: 7180300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fluorescence histochemical study of catecholamine concentrations in the skeletal muscles of patients with different forms of progressive neuromuscular disease].
    Temin PA; Dzhabarov BD; Grinio LP; Kargina-Terent'eva RA; Parshikova MV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(3):31-4. PubMed ID: 7080773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnostic studies in patients and relatives with hereditary neuromuscular diseases].
    Moser H
    Ther Umsch; 1995 Dec; 52(12):810-3. PubMed ID: 8539652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Body-potassium concentation and rubidium metabolism determined by whole-body counting in Duchenne muscular dystrophy and its genetic carrier state.
    Nagai T; Sugita H; Iinuma TA; Furukawa T; Yashiro S
    J Nucl Med; 1969 Jan; 10(1):1-7. PubMed ID: 5797554
    [No Abstract]   [Full Text] [Related]  

  • 7. [Characteristics of carbohydrate-phosphorus and electrolyte metabolism in the erythrocytes of patients with progressive muscular dystrophy and in their closest relations].
    Degtiar VV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1974; 74(3):333-41. PubMed ID: 4466265
    [No Abstract]   [Full Text] [Related]  

  • 8. [Status of connective tissue in progressive muscular dystrophies].
    Sitnikov VF; Temin PA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1979; 79(3):272-6. PubMed ID: 442894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Various features of muscle tissue metabolism in various muscular and neuromuscular diseases of a hereditary nature (clinico-histochemical study)].
    Anosov NN; Saĭkova LA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(3):22-5. PubMed ID: 6952668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular basis of neuromuscular diseases.
    Chance PF; Ashizawa T; Hoffman EP; Crawford TO
    Phys Med Rehabil Clin N Am; 1998 Feb; 9(1):49-81, vi. PubMed ID: 9894134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinico-genalogic characteristics of hereditary diseases of the nervous system in the Kuibyshev region].
    Nesterov LN; Sushcheva GP; Viatkina SIa
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1978; 78(10):1506-12. PubMed ID: 152555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioisotope studies in neuromuscular disease. II. Studies in muscular dystrophy and myotonia dystrophica with sodium 22 and potassium 42.
    BLAHD WH; BAUER FK; LIBBY RL; ROSE AS
    Neurology; 1955 Mar; 5(3):201-7. PubMed ID: 14356349
    [No Abstract]   [Full Text] [Related]  

  • 13. [Catecholamine concentration in the blood and excretion in the urine in different forms of progressive muscular dystrophy].
    Badalian LO; Temin PA; Dzhabarov BD; Bespalova VA; Kret LA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(3):339-42. PubMed ID: 6426220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study of Na24 and K42 metabolism by the method of whole body radiometry in heart disease patients before and after surgical intervention].
    Ryskulbekov AU
    Med Radiol (Mosk); 1974 Apr; 19(4):74-6. PubMed ID: 4218890
    [No Abstract]   [Full Text] [Related]  

  • 15. [Evoked potentials of the somatosensory system in patients with progressive muscular dystrophies].
    Avakian GN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(11):1628-32. PubMed ID: 6675359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Plasma alpha/beta lipoprotein coefficient in the diagnosis of progressive muscular dystrophy].
    Islamova IB
    Lab Delo; 1989; (10):34-5. PubMed ID: 2481069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical study of K42 metabolism by the method of whole body radiometry].
    Palinkashi DG; Ryskulbekov AU
    Med Radiol (Mosk); 1974 Apr; 19(4):71-3. PubMed ID: 4218889
    [No Abstract]   [Full Text] [Related]  

  • 18. [Problem of phenotypic polymorphism in hereditary neuromuscular diseases].
    Badalian LO
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1979; 79(3):257-61. PubMed ID: 571656
    [No Abstract]   [Full Text] [Related]  

  • 19. [Features of the course and treatment of progressive muscular dystrophy associated with chronic suppurative diseases].
    Abdukhakimov FT; Islamov IB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(3):362-7. PubMed ID: 7395411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal polyamine metabolism in hereditary muscular dystrophies: effect of human growth hormone.
    Rudman D; Kutner MH; Chawla RK; Goldsmith MA
    J Clin Invest; 1980 Jan; 65(1):95-102. PubMed ID: 7350201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.